Results 81 to 90 of about 318 (106)

[Retroperitoneal lymphadenopathy trans-vertebral image-guided biopsy: a case report] [PDF]

Rev Fac Cien Med Univ Nac Cordoba, 2022
Rendon FO, Del Valle JB, Valeo Chulvi MP, Dalurzo ML, Santino JP, Borensztein MA.   +5 more
europepmc   +1 more source

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial. [PDF]

Ann Oncol
Monk BJ, Barretina-Ginesta MP, Pothuri B, Vergote I, Graybill W, Mirza MR, McCormick CC, Lorusso D, Moore RG, Freyer G, O'Cearbhaill RE, Heitz F, O'Malley DM, Redondo A, Shahin MS, Vulsteke C, Bradley WH, Haslund CA, Chase DM, Pisano C, Holman LL, Pérez MJR, DiSilvestro P, Gaba L, Herzog TJ, Bruchim I, Compton N, Shtessel L, Malinowska IA, González-Martín A.   +29 more
europepmc   +1 more source

El uso de anticonceptivos orales reduciría el riesgo de cáncer ginecológico

Evidencia. Actualización en la Práctica Ambulatoria, 2008
Juliana Alicia Botbol
doaj   +1 more source

Impact of financial toxicity on adults with cancer during the COVID-19 pandemic: an integrative review. [PDF]

Rev Bras Enferm
Nogueira LA, Ribeiro CO, Silva LDS, Santos YHD, Kalinke LP.   +4 more
europepmc   +1 more source

Preoperative neutrophil/lymphocyte ratio as prognostic factor in epithelial ovarian cancer [PDF]

Rev Colomb Obstet Ginecol
Vázquez Rojo J, Vázquez Reguera J, Sánchez del Río A.   +2 more
europepmc   +1 more source

[Obstetric-gynecological and social factors for the development of cervical intraepithelial neoplasia]. [PDF]

Rev Med Inst Mex Seguro Soc
Villanueva-Duque JA, Castro-Valdés IC, García-Cervantes N.   +2 more
europepmc   +1 more source

Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer. [PDF]

ESMO Open
Nag S, Ray Coquard I, Gupta S, Pathak A, Li N, Mulya Sari R, Harano K, Kim GM, Ang SF, Que FV, Chay WY, Lai HC, Ativitavas T, Tangjitgamol S, Lai CH, Heong VYM, Contreras Tolentino J, Ngu MR, Yun J, Yunokawa M, Hanafi WLH, Li J, Smyth E, Yoshino T, Mehta J, Pentheroudakis G, Maheshwari A, Cervantes A, Basade M, Oaknin A.   +29 more
europepmc   +1 more source

ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. [PDF]

Int J Gynecol Cancer
Vergote I, Perez Fidalgo A, Valabrega G, Monk BJ, Herzog T, Cibula D, Colombo N, Pothuri B, Sehouli J, Korach J, Barlin J, Papadimitriou CA, van Gorp T, Richardson D, McCarthy M, Antill Y, Mirza MR, Li K, Kalyanapu P, Slomovitz B, Coleman RL.   +20 more
europepmc   +1 more source

Effect of a new nursing organization management mode constructed by appreciative inquiry on gynecological tumor patients in the perioperative period. [PDF]

Rev Esc Enferm USP
Fang C, Yang J.
europepmc   +1 more source

Atezolizumab, bevacizumab, and platinum chemotherapy in cervical cancer: results of Japanese population from BEATcc. [PDF]

J Gynecol Oncol
Takekuma M, Nishio S, Yamaguchi S, Yunokawa M, Nishio H, Nishino K, Kurosaki A, Minobe S, Villacampa G, Oaknin A, Okamoto A.   +10 more
europepmc   +1 more source